NewsPharmaceutical

Atopic Dermatitis Market Forecast Period 2019-2026: Velite Pharmaceuticals, Galderma SA, Pfizer Inc, Fujisawa Healthcare, Inc., Dow, Regeneron Pharmaceuticals, Inc, LEO Pharma A/S, Sanofi, Novartis AG

Global Atopic Dermatitis Market By Mechanism of Action Type (Antihistamines, Topical corticosteroids, Emollients, Phosphodieterase-4 (PDE-4) inhibitor, Topical antiseptic and Others),  Mode of Administration (Injectable, Topical, Oral), Drug Type (Triamcinolone, Clobetasol, Tacrolimus topical, Betamethasone, Pimecrolimus, Fluocinonide, Hydrocortisone, Prednisone, Crisaborole, Fluticasone, Methylprednisolone  and Others), Distribution Channel (Mail Order Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores, Retail Pharmacies, Dermatology Clinics), Type (Hormone, Erythropoietin, Monoclonal Antibodies, and Calcitonin), Application (Cancer, Blood Disorders, and Chronic Diseases), End User (Hospitals, Research Centers, Clinics, Home Care), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Forecast to 2026

Get Free Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-atopic-dermatitis-market

Market Analysis: Global Atopic Dermatitis Market

Global Atopic Dermatitis Market in the forecast period of 2019-2026. Growing number of atopic dermatitis population and robust product pipeline are the key drivers for market growth.

Key Market Competitors: Global Atopic Dermatitis Market

Few of the major competitors currently working in the atopic dermatitis market are

  • Velite Pharmaceuticals,
  • Galderma SA,
  • Pfizer Inc,
  • Fujisawa Healthcare, Inc.,
  • Dow,
  • Regeneron Pharmaceuticals, Inc,
  • LEO Pharma A/S,
  • Sanofi,
  • Novartis AG,
  • Bristol-Myers Squibb Company,
  • Bayer AG,
  • Meda Pharmaceuticals Inc.,
  • Connetics Corporation,
  • ALLERGAN,
  • Boehringer Ingelheim International GmbH,
  • GlaxoSmithKline plc,
  • Hoffmann-La Roche AG,
  • Encore Dermatology, Inc.,
  • AbbVie Inc. and few among others.

Key Developments in the Market:

  • In March 2017, Regeneron Pharmaceuticals, Inc. in a collaboration with Sanofi received the US FDA approval for Dupixent (dupilumab) injection for the treatment of moderate to severe atopic dermatitis (AD) in adult patient
  • In December 2016, Pfizer Inc. received the US FDA approval for Eucrisatm (crisaborole), a phosphodieterase-4 (PDE-4) inhibitor for the treatment of mild to moderate atopic dermatitis (AD) in padiatric patient as well as adult patient

Get 10% Discount Instant Mail us @ sopan.gedam@databridgemarketresearch.com

Market Definition: Global Atopic Dermatitis Market

Atopic dermatitis can be defined as a chronic inflammatory skin condition that affects patients of all age group and is a result of a complex interplay of multiple factors including environmental, immunological, genetic, and pharmacologic factors.

According to the article published in National Center for Biotechnology Information 2018, It was estimated that totoal population of atopic dermatitis in the United States over 4.9% ,  in Canada 4.4% and 3.5% in Europe. The prevalent was higher in female as comapared to male. Increasing number of atopic dermatitis cases worldwide and accelerating demand of clinical treatment and novel therapies indicates the significant growth of market.

Market Drivers

  • Strong product pipeline for atopic dermatitis
  • Availability of novel drug therapies and generic alternatives
  • Increase in awareness of atopic dermatitis
  • Growing cases of atopic dermatitis worldwide

Market Restraints

  • Upcoming patent expiry of products of many companies
  • Allergic reactions of off-label therapies
  • Effective treatment is either unavailable or unaffordable

Segmentation: Global Atopic Dermatitis Market

By Mechanism of Action Type

  • Antihistamines
  • Topical corticosteroids
  • Emollients
  • Phosphodieterase-4 (PDE-4) inhibitor
  • Topical antiseptic
  • Others

By Mode of Administration

  • Injectable
  • Topical
  • Oral

By Drug Type

  • Triamcinolone
  • Clobetasol
  • Tacrolimus topical
  • Betamethasone
  • Pimecrolimus
  • Fluocinonide
  • Hydrocortisone
  • Prednisone
  • Crisaborole
  • Fluticasone
  • Methylprednisolone
  • Others

By End- User

  • Hospitals
  • Research Centers
  • Clinics
  • Home Care

By Distribution Channel

  • Mail Order Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • Drug Stores
  • Retail Pharmacies
  • Dermatology Clinics

By Geography

  • North America
    • S.
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific
  • Middle East & Africa
    • South Africa
    • Egypt
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Rest of Middle East & Africa

For More Details In-Depth Inquiry @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-atopic-dermatitis-market

Competitive Analysis: Global Atopic Dermatitis Market

Global atopic dermatitis market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of atopic dermatitis market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

  • Current and future of global atopic dermatitis market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Table of Contents:

  1. Introduction
  2. Market Segmentation
  3. Market Overview
  4. Executive Summary
  5. Premium Insights
  6. Global, By Component
  7. Product Type
  8. Delivery
  9. Industry Type
  10. Geography

10.1.    Overview

10.2.    North America

10.3.    Europe

10.4.    Asia-Pacific

10.5.    South America

10.6.    Middle East & Africa

  1. Company Landscape
  2. Company Profiles
  3. Related Reports

Download Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-atopic-dermatitis-market

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *